Information Provided By: 
Fly News Breaks for February 24, 2017
SPLK
Feb 24, 2017 | 06:15 EDT
Piper Jaffray analyst Alex Zukin believes Splunk's Q1 outlook, which he attributes the post-earnings selloff to, sets an appropriate bar and accounts for greater seasonality and recent territory changes within its sales organization. The analyst views the company's long-term secular growth story as "solid" and says he would be a buyer on today's weakness. Zukin keeps an Overweight rating on Splunk with a $65 price target.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
